Supernus Pharmaceuticals Inc

NASDAQ:SUPN   3:59:53 PM EDT
27.23
-0.08 (-0.29%)
Products

Supernus Pharmaceuticals Inc -On July 13, Co Entered An API Supply Agreement With Bachem Americas Inc

Published: 07/19/2021 20:59 GMT
Supernus Pharmaceuticals Inc (SUPN) - Supernus Pharmaceuticals Inc -on July 13, Co Entered an Api Supply Agreement With Bachem Americas Inc.supernus - Co Will Be Responsible for Costs to Purchase, Install Manufacturing Process Equipment at Bachem’s Cgmp-compliant Facility in Switzerland.
Supernus - Bachem Will Be Responsible for Ordering, Installing, Qualifying, Validating Equipment Required to Support Production of Api.
Supernus - Bachem Will Be Responsible for Ensuring Equipment Meets All Regulatory, Operational Requirements & Can Be Used for Production of Api.
Supernus Pharmaceuticals - Title, Ownership of Equipment Will Belong to Bachem at All Times & Will Survive Termination of Agreement.
Supernus - Agreement With Bachem Will Continue Until July 13, 2026, Unless Earlier Terminated.
Supernus Pharmaceuticals - During Term of Agreement, Bachem Will Supply Api Exclusively to Co.